Treatment Patterns of Follicular Lymphoma in the United States: A Claims Analysis
**Background:** A consensus is lacking on optimal treatment sequencing for follicular lymphoma (FL), the most common indolent lymphoma. FL is incurable, and many patients require multiple lines of therapy for successive relapses. Guidelines provide numerous recommendations for first-, second-, and t...
Saved in:
Main Authors: | Scott F. Huntington, Sreevalsa Appukkuttan, Wenyi Wang, Yuxian Du, Sari Hopson, Svetlana Babajanyan |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2022-10-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/001c.38070 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment Patterns and Health Care Costs in Commercially Insured Patients with Follicular Lymphoma
by: Nathan H. Fowler, et al.
Published: (2020-09-01) -
Deep immunophenotypic dissection and clinical impact of T cells in the follicular lymphoma microenvironment
by: Sary El Daker, et al.
Published: (2025-02-01) -
Plasmablastic transformation of a double hit follicular lymphoma: An emerging entity
by: Shanaz Khodaiji, et al.
Published: (2024-04-01) -
Impact of positive CD4 cells on event‐free survival in follicular lymphoma patients
by: Cong Li, et al.
Published: (2024-09-01) -
The age-adjusted international prognostic index 2 (A-FLIPI2) for elderly patients with follicular lymphoma
by: Jiesong Wang, et al.
Published: (2025-02-01)